The new trial would join a small number of other therapies in human trials for ALS, including a nerve-protectant called TCH-346 in second-stage trials at the Swiss drug firm Novartis (nyse: NVS - news - people ).

FORBES: Gene Therapy Slows A Killer

Paris (France), Las Vegas (NV), January 7, 2013 - Technicolor (Euronext Paris: TCH), a worldwide technology leader in the media and entertainment sector, today announced the release of Qeo, a software framework that allows for seamless interoperability between devices and applications of all brands and ecosystems.

ENGADGET: Technicolor's Qeo software aims to let connected devices speak the same lingo